Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 4/20 | 0.42 |
| ▸ | GRPR | P30550 | 4/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.37 |
| ▸ | YWHAZ | P63104 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.36 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.36 |
| ▸ | BECN1 | Q14457 | 2/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
| ▸ | CTSE | P14091 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32678599 | 1.00 | KEAP1 (0.42) | KEAP1GRPREGFRRENYWHAZ | |
| SCHEMBL22922937 | 0.93 | KEAP1 (0.40) | KEAP1GRPREGFRRENYWHAZ | |
| SCHEMBL29384660 | 0.92 | TERT (0.39) | KEAP1RENCALCRLTERT | |
| SCHEMBL31461867 | 0.90 | KEAP1 (0.46) | KEAP1GRPRRENYWHAZMAPK8 | |
| SCHEMBL29421977 | 0.87 | KEAP1 (0.44) | KEAP1GRPRYWHAZMAPK8MAPK9 | |
| SCHEMBL29485647 | 0.86 | KEAP1 (0.43) | KEAP1GRPRYWHAZMAPK8MAPK9 | |
| SCHEMBL29630716 | 0.85 | DPP7 (0.38) | KEAP1TERT | |
| SCHEMBL29517049 | 0.85 | DPP7 (0.41) | TERT | |
| SCHEMBL31320748 | 0.85 | EGFR (0.40) | KEAP1GRPREGFRRENYWHAZ | |
| SCHEMBL29914541 | 0.84 | MEN1 (0.42) | CALCRLCTSDTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053401-A1 | HYDROGEL BALL | COYLE BRIAN MICHAEL (US) | 2026-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053401-A1 | HYDROGEL BALL | MMP2, MMP13, MMP9 | KEAP1 3515/4885GRPR 1063/4885EGFR 2549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.